Stock data
Ironwood Pharmaceuticals, Inc. (IRWD)
Ironwood Pharmaceuticals, Inc. (IRWD) reported revenue of US$296.15M and net income of US$24.02M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$296.15M | — | US$98.50M | US$24.02M | — |
| 2024 | US$351.41M | — | US$93.12M | US$0.88M | — |
| 2023 | US$442.74M | — | -US$945.43M | -US$1.00B | — |
| 2022 | US$410.60M | — | US$250.34M | US$175.06M | — |
| 2021 | US$413.75M | — | US$232.26M | US$528.45M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$113.04M | US$51.29M | — |
| 2026-03-31 | US$106.51M | US$40.77M | — |
| 2025-12-31 | US$47.71M | -US$2.28M | — |
| 2025-09-30 | US$122.06M | US$40.08M | — |
| 2025-06-30 | US$85.24M | US$23.60M | — |
| 2025-03-31 | US$41.14M | -US$37.39M | — |
| 2024-12-31 | US$90.55M | US$2.26M | — |
| 2024-09-30 | US$91.59M | US$3.65M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.